BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

FHLCvsBMEDETF Comparison

ETF 1

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

+0.14%

Full FHLC fund page

VS

ETF 2

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

+0.13%

Full BMED fund page

Fidelity MSCI Health Care Index ETF (FHLC) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. FHLC is less expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.77% for BMED. FHLC is up 16.94% year-to-date (YTD) with +$478M in YTD flows. BMED performs better with 17.07% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of FHLC and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

FHLC vs BMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/26/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	FHLC BMED	+3.76%+1.26%	+8.83%+14.99%	+16.94%+17.07%	+23.63%+23.95%	+53.42%+68.15%	+39.86%+19.50%
Flows	FHLC BMED	+$77M-	+$226M+$1M	+$478M+$5M	+$542M+$6M	-$184M+$7M	+$18M+$6M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	FHLC BMED	+17.04%+21.82%	+15.91%+17.97%	+14.92%+16.84%	+15.51%+18.16%
Max drawdown	FHLC BMED	-5.64%-5.85%	-10.35%-14.71%	-16.88%-19.76%	-17.78%-32.14%
Max drawdown duration	FHLC BMED	56d31d	169d196d	435d237d	762d1479d

Trading data

Create an account to view trading data

Join for free

	FHLC	BMED
Last sale 10/27/2026 at 1:30 PM	$86.08	$35.64
Previous close 10/26/2026	$86.00	$35.34
Consolidated volume 10/26/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	FHLC	BMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/27/2026 at 1:30 PM

Live

Closed

	FHLC	BMED
Last price	$86.08	$35.64
1D performance	+0.09%	+0.85%
AuM	$3.82 B	$14.14 M
E/R	0.084%	0.77%

Characteristics

	FHLC	BMED
Management strategy	Passive	Active
Provider	Fidelity	iShares
Benchmark	MSCI USA IMI Health Care 25/50 Index	-
N° of holdings	338	53
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	October 21, 2013	September 29, 2020
ESG	No	No

More FHLC data on Trackinsight

More BMED data on Trackinsight

Exposure

Countries

FHLC

USA

97.14%

Other

2.86%

BMED

USA

87.23%

Other

12.77%

Sectors

FHLC

Healthcare

98.23%

Other

1.77%

BMED

Healthcare

98.95%

Other

1.05%

Diversification

FHLC

Total weight of top 15 holdings out of 15

60.85%

BMED

Total weight of top 15 holdings out of 15

58.7%

Top 15 holdings

Data as of August 31, 2026

FHLC

Eli Lilly & Co.

12.94%

Johnson & Johnson

8.88%

AbbVie, Inc.

6.21%

Merck & Co., Inc.

5.04%

UnitedHealth Group, Inc.

4.91%

Amgen, Inc.

3.21%

Thermo Fisher Scientific, Inc.

3.19%

Abbott Laboratories

2.69%

Gilead Sciences, Inc.

2.49%

Pfizer Inc.

2.19%

Vertex Pharmaceuticals, Inc.

1.90%

Danaher Corp.

1.89%

Bristol Myers Squibb Co.

1.87%

Intuitive Surgical, Inc.

1.82%

CVS Health Corp.

1.63%

BMED

Gilead Sciences, Inc.

5.01%

Merck & Co., Inc.

4.99%

AbbVie, Inc.

4.61%

Johnson & Johnson

4.27%

Charles River Laboratories International, Inc.

4.22%

Thermo Fisher Scientific, Inc.

4.12%

Edwards Lifesciences Corp.

3.95%

Moderna, Inc.

3.86%

IQVIA Holdings, Inc.

3.72%

Danaher Corp.

3.64%

Vertex Pharmaceuticals, Inc.

3.56%

Waters Corp.

3.53%

Biogen, Inc.

3.45%

Mettler-Toledo International, Inc.

3.16%

DexCom, Inc.

2.61%

Frequently asked questions about FHLC and BMED

How have the FHLC and BMED ETFs performed in 2026?

As of October 26, 2026, FHLC is up 16.94% year-to-date (YTD), while BMED has returned 17.07%. That puts BMED better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or BMED?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$5M for BMED.

Which ETF is more volatile: FHLC or BMED?

Over the past year, FHLC had a volatility of 15.91%, while BMED experienced 17.97%.

Which ETF is bigger: FHLC or BMED?

As of October 26, 2026, FHLC holds $3.82 B in assets under management (AUM), while BMED manages $14.14 M.

What sectors do the FHLC and BMED ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the FHLC ETF and BMED ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. BMED holds in its top three: Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc..

FHLCvsBMEDETF Comparison

Fidelity MSCI Health Care Index ETF

iShares Health Innovation Active ETF

FHLC vs BMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the FHLC and BMED ETFs performed in 2026?

As of October 26, 2026, FHLC is up 16.94% year-to-date (YTD), while BMED has returned 17.07%. That puts BMED better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or BMED?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$5M for BMED.

Which ETF is more volatile: FHLC or BMED?

Over the past year, FHLC had a volatility of 15.91%, while BMED experienced 17.97%.

Which ETF is bigger: FHLC or BMED?

As of October 26, 2026, FHLC holds $3.82 B in assets under management (AUM), while BMED manages $14.14 M.

What sectors do the FHLC and BMED ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the FHLC ETF and BMED ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. BMED holds in its top three: Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc..

Which ETF is more diversified: FHLC or BMED?

FHLC holds 338 securities with 60.85% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 58.7%.

ETFs’ Next Act: From Access to Selection